Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wilfried E E Eberhardt

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|August 16, 2015
Multimodal treatment of non-small-cell lung cancerWilfried E E Eberhardt, Martin Stuschke
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2024
History Can Teach Us Something: Angiogenesis Inhibition RevisitedWilfried E E Eberhardt, Martin Sebastian
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Chemotherapy in stage III non-small cell lung cancerWilfried E E Eberhardt, Rodrigo Hepp
Current Opinion in Oncology|January 21, 2014
Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvementsDaniel C Christoph, Wilfried E E Eberhardt
Journal of Thoracic Disease|October 23, 2018
Clinical implications of the innovations in the primary tumour and metastasis of the 8<sup>th</sup> edition of the TNM classification for lung cancerRamón Rami-Porta, Wilfried E E Eberhardt
Lancet (London, England)|July 28, 2009
Surgery in stage III non-small-cell lung cancerWilfried E E Eberhardt, Georgios Stamatis, Martin Stuschke
Hematology/Oncology Clinics of North America|April 19, 2005
The role of surgery in stage IIIA non-small cell lung cancerWilfried E E Eberhardt, Rodrigo Hepp, Georgios Stamatis
Oncology Research and Treatment|September 9, 2014
Benefits and risks of lung cancer screeningKarl-Matthias Deppermann, Hans Hoffmann, Wilfried E E Eberhardt
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
Too Good to be True?Martin Sebastian, Jan Alexander Stratmann, Wilfried E E Eberhardt
Cancers|June 12, 2026
Real-World Emulation of Landmark Lung Cancer Trials: A Registry-Based Reconstruction of KN189, KN407, IMpower133, and PACIFICIrina Surovtsova, Wilfried E E Eberhardt, Dorothea E Meschke, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|August 16, 2015
Multimodal treatment of non-small-cell lung cancerWilfried E E Eberhardt, Martin Stuschke
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 7, 2024
History Can Teach Us Something: Angiogenesis Inhibition RevisitedWilfried E E Eberhardt, Martin Sebastian
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Chemotherapy in stage III non-small cell lung cancerWilfried E E Eberhardt, Rodrigo Hepp
Current Opinion in Oncology|January 21, 2014
Systemic treatment of malignant pleural mesothelioma: new agents in clinical trials raise hope of relevant improvementsDaniel C Christoph, Wilfried E E Eberhardt
Journal of Thoracic Disease|October 23, 2018
Clinical implications of the innovations in the primary tumour and metastasis of the 8<sup>th</sup> edition of the TNM classification for lung cancerRamón Rami-Porta, Wilfried E E Eberhardt
Lancet (London, England)|July 28, 2009
Surgery in stage III non-small-cell lung cancerWilfried E E Eberhardt, Georgios Stamatis, Martin Stuschke
Hematology/Oncology Clinics of North America|April 19, 2005
The role of surgery in stage IIIA non-small cell lung cancerWilfried E E Eberhardt, Rodrigo Hepp, Georgios Stamatis
Oncology Research and Treatment|September 9, 2014
Benefits and risks of lung cancer screeningKarl-Matthias Deppermann, Hans Hoffmann, Wilfried E E Eberhardt
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2021
Too Good to be True?Martin Sebastian, Jan Alexander Stratmann, Wilfried E E Eberhardt
Cancers|June 12, 2026
Real-World Emulation of Landmark Lung Cancer Trials: A Registry-Based Reconstruction of KN189, KN407, IMpower133, and PACIFICIrina Surovtsova, Wilfried E E Eberhardt, Dorothea E Meschke, et al.
Pageof 7